Department of Defense Congressionally Directed Medical Research Programs Breast Cancer Research Program Innovator Award

SUBMISSION AND REVIEW DATES AND TIMES
• Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), June 25, 2013
• Invitation to Submit an Application: August 2013
• Confidential Letters of Recommendation Submission Deadline: 5:00 p.m. ET, September 25, 2013
• Application Submission Deadline: 11:59 p.m. ET, September 25, 2013
• Peer Review: November 2013
• Programmatic Review, Stage 1: January 2014
• Invitation for Oral Presentation: January 2014
• Programmatic Review, Stage 2: February 2014


Applications to the Fiscal Year 2013 (FY13) Breast Cancer Research Program (BCRP) are being solicited for the Assistant Secretary of Defense for Health Affairs, Defense Health Program (DHP), by the U.S. Army Medical Research Acquisitions Activity (USAMRAA). The BCRP was initiated in fiscal year 1992 (FY92) to support innovative, high-impact research focused on ending breast cancer. Appropriations for the BCRP from FY92 through FY12 totaled $2.8 billion. The FY13 appropriation is $120.0 million (M).
The BCRP challenges the scientific community to design research that will address the urgency of ending breast cancer. Specifically, the BCRP seeks to accelerate high-impact research with clinical relevance, encourage innovation and stimulate creativity, facilitate multidisciplinary collaborations, and support future breast cancer leaders.